| Literature DB >> 34797836 |
Kim Henry1, Aurélie Mayet2,3, Miguel Hernandez1,4, Guillaume Frechard5, Pierre-Antoine Blanc5, Marion Schmitt6, Nathalie André7, Jean-Marie Loreau2, Marine Ginouves8, Ghislaine Prévot8,9, Pierre Couppié4,8,10, Magalie Demar1,4,8, Romain Blaizot4,8,10.
Abstract
BACKGROUND: Cutaneous Leishmaniasis (CL) is endemic in French Guiana but cases are usually sporadic. An outbreak signal was issued on May 15th 2020 with 15 suspected cases after a military training course in the rainforest. An outbreak investigation was carried out. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2021 PMID: 34797836 PMCID: PMC8641862 DOI: 10.1371/journal.pntd.0009938
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
General characteristics of confirmed cases of Cutaneous Leishmaniasis, CEFE outbreak, French Guiana, 2020 (n = 30).
| Number of patients, (%) | |
|---|---|
|
| 32 |
| 30 (100%) | |
|
| |
| A | 16 (53.3%) |
| B | 14 (46.7%) |
|
| |
| Instructor (always present) | 1 (3.3%) |
| Week 4 to Week 12 | 1 (3.3%) |
| Weeks 6–7 | 1 (3.3%) |
| Week 13–14 | 20 (66.7%) |
| Week 16–17 | 4 (13.3%) |
| Week 17–20 | 2 (6.7%) |
| Week 19–20 | 1 (3.3%) |
|
| |
| Fighting | 24 (80.0) |
| Other trainees | 4 (13.3%) |
| Rainforest specialist | 2 (6.67%) |
| International training course « Jaguar » | 2 (6.67%) |
| Instructor | 2 (6.67%) |
|
| 0 |
|
| |
| Upper limbs | 19 (63.3%) |
| Hands | 12 (40%) |
| Lower limbs | 13 (43.3%) |
| Trunk | 7 (23.3%) |
| Face | 12 (40%) |
| Neck | 6 (20%) |
| Scalp | 2 (6.7%) |
|
| |
| Ulceration | 27 (90%) |
| Nodule | 6 (20%) |
| Papule | 5 (16.7%) |
| Other | 1 (3.3%) |
|
| 4.33 |
|
| 3 (1–6) |
|
| 0 |
|
| 4 (13.3%) |
|
| 1 (3.3%) |
|
| |
| Positive smear | 16 (53.3%) |
| Positive culture | 11 (36.7%) |
| Including MALDI-TOF identification | 11 (36.7%) |
| Positive PCR | 26 (86.7%) |
|
| |
|
| 27 (90%) |
| 1 (3.3%) | |
| Unknown (no PCR or negative PCR) | 2 (6.6%) |
|
| |
| Pentamidine | 30 (100%) |
|
| |
| Good response | 15 (50%) |
| Bad response/failure | 10 (33.3%) |
| Lost to follow-up | 5 (16.7%) |
| 8 (26.7%) | |
| Pentamidine (2nd injection) | 2 (25%) |
| Amphotericin B | 6 (75%) |
|
| 8 |
| Good response | 2 (25%) |
| Bad response | 3 (37.5%) |
| Lost to follow-up | 3 (37.5%) |
Risk factors of Cutaneous Leishmaniasis, case-control study, univariate analysis, confirmed cases of the CEFE outbreak and military controls, French Guiana, 2020.
| Cases | Controls | OR (95%CI) | p-value | |
|---|---|---|---|---|
|
| ||||
|
| ||||
| • <30 | 9 (40.9%) | 10 (45.45%) | 0.83 (0.22–3.22) | 0.761 |
| • ≥30 | 13 (59.1%) | 12 (54.6%) | - | |
|
| ||||
| • Private | 19 (86.4%) | 13 (59.1%) | 4.38 (0.84–29.03) | 0.088 |
| • Non-commissioned officer | 2 (3.9%) | 6 (27.3%) | - | |
| • Officer | 1 (4.6%) | 3 (13.6%) | ||
|
| ||||
| • A | 13 (59.1%) | 19 (86.36%) | 0.24 (0.03–1.18) | 0.088 |
| • B | 9 (40.9%) | 3 (13.64%) | - | |
|
| ||||
| • Yes | 10 (45.45%) | 6 (27.3%) | 2.2 (0.54–9.56) | 0.210 |
| • No | 12 (54.6%) | 16 (72.7%) | - | |
|
| ||||
| • Fighting | 16 (72.7%) | 22 (100%) |
|
|
| • Rainforest specialist | 2 (9.1%) | 0 | - | |
| • Jaguar | 2 (9.1%) | 0 | ||
| • No training: instructor | 2 (9.1%) | 0 | ||
|
| ||||
| • Week 4 to Week 12 | 2 (9.1%) | 0 | - | |
| • Week 6 to Week 7 | 1 (4.5%) | 9 (40.9%) | ||
| • |
|
|
|
|
| • Week 16 to Week 17 | 3 (13.6%) | 4 (18.2%) | - | |
| • Week 19 to Week 20 | 1 (4.5%) | 0 | ||
| • Week 21 to Week 22 | 0 | 2 (9.1%) | ||
|
| ||||
| • Yes | 5 (22.7%) | 0 | 5.95 (0.58–305.73) | 0.185 |
| • No | 17 (77.3%) | 22 (100%) | - | |
|
| ||||
|
| ||||
| • Yes | 21 (95.45%) | 19 (86.4%) | 3.23 (0.24–182.19) | 0.607 |
| • No | 1 (4.55%) | 3 (13.6%) | - | |
|
| ||||
| • Yes | 19 (86.4%) | 17 (77.3%) | 1.84 (0.30–13.64) | 0.698 |
| • No | 3 (13.6%) | 5 (22.7%) | - | |
|
| ||||
| • Yes | 21 (95.5%) | 21 (95.5%) | 1 (0.01–82.18) | 1 |
| • No | 1 (4.5%) | 1 (4.5%) | - | |
|
| ||||
| • Yes | 18 (81.8%) | 21 (95.5%) | 3.32 (0.24–182.18) | 0.345 |
| • No | 4 (18.2%) | 1 (4.5%) | - | |
|
| ||||
|
| ||||
| • Daily | 18 (81.8%) | 19 (86.4%) | 0.72 (0.092–4.89) | 1.000 |
| • Sometimes | 4 (18.2%) | 3 (13.6%) | - | |
|
| ||||
| • Provided by the army | 15 (68.2%) | 11 (50%) | 2.14 (0.54–8.78) | 0.220 |
| • Personal | 7 (31.8%) | 11 (50%) | - | |
|
| ||||
| • Yes | 22 (100%) | 22 (100%) | - | |
| • No | 0 | 0 | - | |
|
| ||||
| • Yes | 3 (13.6%) | 2 (9.1%) | 1.58 (0.16–20.65) | 1.000 |
| • No | 19 (86.4%)) | 20 (90.9%) | - | |
|
| ||||
| • Yes | 3 (13.6%) | 2 (9.1%) | 1.58 (0.16–20.65) | 1.000 |
| • No | 19 (86.4%) | 20 (90.9%) | - | - |
|
| ||||
| • Daily | 13 (59.1%) | 16 (72.7%) | - | |
| • Sometimes | 8 (36.4%) | 3 (13.6%) | 1.18 (0–2.59) | 0.163 |
Comparison of attack rates of CL in French Guiana during the study period, according to attendance of a CEFE course and regiment, 2020.
| Cases of CL | Total | Attack rate | OR (95%IC) | p-value | |
|---|---|---|---|---|---|
|
| |||||
| • French Guiana, CEFE excluded | 22 | 1427 | 1.54% | - | |
| • CEFE | 30 | 858 | 3.5% |
|
|
|
| |||||
| • Military unit A | 16 | 507 | 3.16% | - | |
| • Military unit B | 14 | 105 | 13.33% |
|
|